AbbVie
ABBVHealth careStock · Data from SEC EDGAR 13F · Held by 16 of 87 tracked investors
AbbVie at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation8
- Growth49
- Profitability78
- Quality92
- Debt63
- Stability83
- Nothing notable from the statements.
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 31 Jul 2026 | 3.65 | 3.64 | +0.3% |
| Mar 2026 | 29 Apr 2026 | 2.65 | 2.62 | +1.2% |
| Dec 2025 | 4 Feb 2026 | 2.71 | 2.66 | +1.9% |
| Sep 2025 | 31 Oct 2025 | 1.86 | 1.77 | +5.1% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart ABBV
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
16KF Ken Fisher Fisher Investments | 0.71% |
Čn Česká národní banka Česká národní banka | 0.7% |
LR Larry Robbins Glenview Capital | 0.68% |
Šn Švýcarská národní banka Swiss National Bank | 0.66% |
Ns Norský státní fond Norges Bank | 0.64% |
GI Generali Investments CEE Generali Investments CEE | 0.43% |
CA Cliff Asness AQR Capital Management | 0.18% |
IE Israel Englander Millennium Management | 0.14% |
SC Steven Cohen Point72 Asset Management | 0.1% |
KG Ken Griffin Citadel Advisors | 0.09% |
JG Joel Greenblatt Gotham Asset Management | 0.06% |
MG Mario Gabelli GAMCO Investors | 0.03% |
TR Thomas Russo Gardner Russo & Quinn | 0.03% |
RD Ray Dalio Bridgewater Associates | 0.01% |
JY Jeff Yass Susquehanna International Group | 0.01% |
BN Bill Nygren Oakmark (Harris Associates) | 0% |
Frequently asked questions
How much is AbbVie (ABBV) stock?
AbbVie shares trade at $285.64, +0.16% over the last trading day. The price is delayed.
What is the market cap of AbbVie?
The market cap of AbbVie is about $505B and its price-to-earnings ratio (P/E) is 80.7.
Does AbbVie pay a dividend?
The dividend yield of AbbVie is 2.43% a year. The yield can change with the company's decisions.
How has AbbVie stock performed over the last year?
The AbbVie share price changed by +25.29% over 12 months and by +149.10% over 5 years.
Which big investors hold AbbVie?
According to the latest 13F filings, 16 of 87 tracked investors hold AbbVie, for example Ken Fisher, Česká národní banka, Larry Robbins.
When will AbbVie report its next results?
The next earnings report of AbbVie is expected on 30 Oct 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.